Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Duarte-Garcia

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Rheumatology (Oxford, England)|March 24, 2022
Soluble LILRA3 is aberrantly expressed in antiphospholipid syndrome (APS) and is a potential marker of thrombotic APSHongjiang Liu, Chun Li, Hui Shi, et al.
RMD Open|February 22, 2024
Association between sinusitis and incident rheumatic diseases: a population-based studyVanessa L Kronzer, John M Davis, Andrew C Hanson, et al.
Lupus|October 26, 2020
16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment TrendsHannah Cohen, Maria J Cuadrado, Doruk Erkan, et al.
Lupus Science & Medicine|December 11, 2025
Risk factors and outcomes of posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a retrospective-multicentre cohort study and systematic literature reviewAli Ardekani, Alain Sanchez-Rodriguez, Mariana Gonzalez-Treviño, et al.
Kidney International Reports|July 9, 2025
The Clinicopathologic Characteristics of Recurrent Lupus Nephritis Post-Transplant Using Surveillance and Indication BiopsiesMaria Lourdes Gonzalez Suarez, Wen Jiqiu, Andrea G Kattah, et al.
Seminars in Arthritis and Rheumatism|September 15, 2020
Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping reviewAdam Kilian, Yu Pei Chock, Irvin J Huang, et al.
Seminars in Arthritis and Rheumatism|January 28, 2024
OMERACT 2023 Systemic Lupus Erythematosus Special Interest Group: Winnowing and Binning Preliminary Candidate Domains for the Core Outcome SetWils Nielsen, Vibeke Strand, Lee S Simon, et al.
Rheumatology (Oxford, England)|December 12, 2025
International development and validation of a multilingual bank of items for the self-assessment of essential knowledge by systemic lupus erythematosus patients: the SLE Knowledge Assessment score (SLAKE)Antonin Satrin, Matteo Piga, Mariele Gatto, et al.
Annals of the Rheumatic Diseases|November 20, 2025
Clinical and biologic predictors of thrombosis in persistently antiphospholipid antibody-positive patients: Prospective analysis of the International APS ACTION Clinical Database and Repository ('Registry')Jonathan Thaler, Michael Parides, Danieli Castro Oliveira de Andrade, et al.
The Journal of Rheumatology|September 2, 2021
COVID-19 in Pregnant Women With Rheumatic Disease: Data From the COVID-19 Global Rheumatology AllianceBonnie L Bermas, Milena Gianfrancesco, Helen L Tanner, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Rheumatology (Oxford, England)|March 24, 2022
Soluble LILRA3 is aberrantly expressed in antiphospholipid syndrome (APS) and is a potential marker of thrombotic APSHongjiang Liu, Chun Li, Hui Shi, et al.
RMD Open|February 22, 2024
Association between sinusitis and incident rheumatic diseases: a population-based studyVanessa L Kronzer, John M Davis, Andrew C Hanson, et al.
Lupus|October 26, 2020
16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment TrendsHannah Cohen, Maria J Cuadrado, Doruk Erkan, et al.
Lupus Science & Medicine|December 11, 2025
Risk factors and outcomes of posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a retrospective-multicentre cohort study and systematic literature reviewAli Ardekani, Alain Sanchez-Rodriguez, Mariana Gonzalez-Treviño, et al.
Kidney International Reports|July 9, 2025
The Clinicopathologic Characteristics of Recurrent Lupus Nephritis Post-Transplant Using Surveillance and Indication BiopsiesMaria Lourdes Gonzalez Suarez, Wen Jiqiu, Andrea G Kattah, et al.
Seminars in Arthritis and Rheumatism|September 15, 2020
Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping reviewAdam Kilian, Yu Pei Chock, Irvin J Huang, et al.
Seminars in Arthritis and Rheumatism|January 28, 2024
OMERACT 2023 Systemic Lupus Erythematosus Special Interest Group: Winnowing and Binning Preliminary Candidate Domains for the Core Outcome SetWils Nielsen, Vibeke Strand, Lee S Simon, et al.
Rheumatology (Oxford, England)|December 12, 2025
International development and validation of a multilingual bank of items for the self-assessment of essential knowledge by systemic lupus erythematosus patients: the SLE Knowledge Assessment score (SLAKE)Antonin Satrin, Matteo Piga, Mariele Gatto, et al.
Annals of the Rheumatic Diseases|November 20, 2025
Clinical and biologic predictors of thrombosis in persistently antiphospholipid antibody-positive patients: Prospective analysis of the International APS ACTION Clinical Database and Repository ('Registry')Jonathan Thaler, Michael Parides, Danieli Castro Oliveira de Andrade, et al.
The Journal of Rheumatology|September 2, 2021
COVID-19 in Pregnant Women With Rheumatic Disease: Data From the COVID-19 Global Rheumatology AllianceBonnie L Bermas, Milena Gianfrancesco, Helen L Tanner, et al.
Pageof 3